David Stevens

Directeur/Membre du Conseil chez AMPIO PHARMACEUTICALS, INC.

Profil

David R.
Stevens is currently the Chairman at Advanced Headache Intervention, Inc. He is also an Independent Director at Ampio Pharmaceuticals, Inc. and a Director at Cetya Therapeutics, Inc. Previously, Dr. Stevens served as the President & Chief Executive Officer at Deprenyl Animal Health, Inc. from 1990 to 1998.
He was also the Executive Chairman at Surginetics LLC, Chairman at CanCog Technologies, Inc., and Executive Chairman at Cedus, Inc. from 2012 to 2014.
Additionally, he held the position of Director at Poniard Pharmaceuticals, Inc. from 2004 to 2013 and Director at Smart Drug Systems, Inc. from 1999 to 2006.
He served as a Non-Executive Director at AquaBounty Technologies, Inc. from 2002 to 2012 and as a Director at Micro-Imaging Solutions LLC from 2007 to 2018.
Furthermore, he was the Vice President-Research & Development at Agrion Corp.
from 1986 to 1988.
Dr. Stevens obtained a doctorate degree from the University of California, Davis and holds undergraduate and doctorate degrees from Washington State University.

Postes actifs de David Stevens

Sociétés	Poste	Début
AMPIO PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	01/06/2011
Advanced Headache Intervention, Inc.	Président	01/06/2010
Cetya Therapeutics, Inc.	Directeur/Membre du Conseil	01/11/2013

Anciens postes connus de David Stevens

Sociétés	Poste	Fin
Micro-Imaging Solutions LLC	Directeur/Membre du Conseil	01/01/2018
Cedus, Inc.	Président	01/01/2014
PONIARD PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	01/01/2013
AQUABOUNTY TECHNOLOGIES, INC.	Directeur/Membre du Conseil	25/07/2012
Smart Drug Systems, Inc.	Directeur/Membre du Conseil	01/01/2006